Drug class in one race

Serotonin 5-HT2A / dopamine D1-D2 receptor drugs for Schizophrenia

2 tracked Serotonin 5-HT2A / dopamine D1-D2 receptor drugs in the Schizophrenia race. The class explanation lives on the Serotonin 5-HT2A / dopamine D1-D2 receptor page; the full indication pipeline across every mechanism is on the Schizophrenia page.

2 approved / phase 4

Head-to-head evidence: Lumateperone vs Risperidone (Risperdal)

The roster

← all Serotonin 5-HT2A / dopamine D1-D2 receptor drugs